Exact Mass: 889.3288
Exact Mass Matches: 889.3288
Found 11 metabolites which its exact mass value is equals to given mass value 889.3288,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6a, 3'-p-Dihydroxypaclitaxel
4,12-bis(acetyloxy)-1,8,9,17,17-pentahydroxy-15-{[2-hydroxy-3-(4-hydroxyphenyl)-3-(phenylformamido)propanoyl]oxy}-10,14-dimethyl-11-oxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-2-yl benzoate
6a, 3-p-Dihydroxypaclitaxel is a metabolite of paclitaxel. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a U.S. National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it taxol. When it was developed commercially by Bristol-Myers Squibb (BMS) the generic name was changed to paclitaxel and the BMS compound is sold under the trademark Taxol. (Wikipedia)
(2s)-n-[(3r,6r,9r,15r,16r)-12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
(2s)-n-[(3r,6r,9r,15r,16r)-12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
n-[12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
n-[12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
(2s)-n-[(3s,6r,9r,15r,16r)-12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
(2s)-n-[(3s,6r,9r,15r,16r)-12-benzyl-3,6-bis(3,5-dihydroxyphenyl)-5,8,11,14-tetrahydroxy-9,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-3-phenyl-2-(1h-pyrrol-2-ylformamido)propanimidic acid
15-(4,5-dihydroxy-6-methyloxan-2-yl)-8-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-3,14-dihydroxy-18-(4-hydroxyphenyl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
15-(4,5-dihydroxy-6-methyloxan-2-yl)-8-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-3,14-dihydroxy-18-(4-hydroxyphenyl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
15-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-8-{[(2r,4r,5r,6r)-5-{[(2r,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-3,14-dihydroxy-18-(4-hydroxyphenyl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
15-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-8-{[(2r,4r,5r,6r)-5-{[(2r,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-3,14-dihydroxy-18-(4-hydroxyphenyl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
4-{[(4-{4-[(2s,3r)-2-[(4-{[(4-aminophenyl)(hydroxy)methylidene]amino}phenyl)formamido]-3-(c-hydroxycarbonimidoyl)-3-methoxypropanamido]benzamido}-2-hydroxy-3-isopropoxyphenyl)(hydroxy)methylidene]amino}-3-isopropoxybenzoic acid
4-{[(4-{4-[(2s,3r)-2-[(4-{[(4-aminophenyl)(hydroxy)methylidene]amino}phenyl)formamido]-3-(c-hydroxycarbonimidoyl)-3-methoxypropanamido]benzamido}-2-hydroxy-3-isopropoxyphenyl)(hydroxy)methylidene]amino}-3-isopropoxybenzoic acid
